Sanofi.png
Sanofi UK marketing authorisation granted for Sanofi Pasteur’s Trivalent Influenza Vaccine (Split Virion, Inactivated) High Dose▼(TIV High Dose)
January 21, 2019 12:32 ET | Sanofi Pasteur
Press Release  Source: Sanofi (EURONEXT: SAN) (NASDAQ: SNY)   UK marketing authorisation granted for Sanofi Pasteur’s Trivalent Influenza Vaccine (Split Virion, Inactivated) High Dose▼(TIV High Dose) ...